|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:drug
|
|
gptkbp:administeredBy
|
gptkb:tablet
oral solution
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
|
|
gptkbp:ATCCode
|
A16AX03
|
|
gptkbp:CASNumber
|
1716-12-7
|
|
gptkbp:chemicalFormula
|
C10H11NaO2
|
|
gptkbp:discoveredBy
|
20th century
|
|
gptkbp:eliminationHalfLife
|
0.8-1 hour
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:has_trade_name
|
gptkb:Buphenyl
gptkb:Ravicti
|
|
gptkbp:hasInChIKey
|
QWESDIXLSGZNPB-UHFFFAOYSA-M
|
|
gptkbp:hasSMILES
|
C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]
|
|
gptkbp:hasUNII
|
H8A007M85H
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
sodium phenylbutyrate
|
|
gptkbp:is_salt_of
|
phenylbutyric acid
|
|
gptkbp:IUPACName
|
sodium 4-phenylbutanoate
|
|
gptkbp:KEGGID
|
gptkb:D08402
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
histone deacetylase inhibitor
ammonia scavenger
|
|
gptkbp:meltingPoint
|
285 °C
|
|
gptkbp:metabolism
|
phenylacetate
|
|
gptkbp:molecularWeight
|
186.18 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
4720
4558
CHEMBL1201
DB00544
CHEBI:9120
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
vomiting
loss of appetite
body odor
menstrual irregularities
|
|
gptkbp:usedFor
|
gptkb:urea_cycle_disorders
amyotrophic lateral sclerosis
spinal muscular atrophy
|
|
gptkbp:bfsParent
|
gptkb:Buphenyl
|
|
gptkbp:bfsLayer
|
8
|